nodes	percent_of_prediction	percent_of_DWPC	metapath
Montelukast—SLCO2B1—Conjugated Estrogens—osteoporosis	0.155	0.219	CbGbCtD
Montelukast—SLCO2B1—Estradiol—osteoporosis	0.136	0.192	CbGbCtD
Montelukast—CYP2C9—Estropipate—osteoporosis	0.05	0.0706	CbGbCtD
Montelukast—CYP2C8—Raloxifene—osteoporosis	0.0478	0.0675	CbGbCtD
Montelukast—CYP2C8—Ethinyl Estradiol—osteoporosis	0.0462	0.0652	CbGbCtD
Montelukast—CYP2C8—Cholecalciferol—osteoporosis	0.0369	0.0521	CbGbCtD
Montelukast—CYP2C8—Estradiol—osteoporosis	0.0297	0.042	CbGbCtD
Montelukast—CYP3A4—Estropipate—osteoporosis	0.029	0.041	CbGbCtD
Montelukast—CYP3A4—Calcitriol—osteoporosis	0.029	0.041	CbGbCtD
Montelukast—CYP2C9—Cholecalciferol—osteoporosis	0.0257	0.0364	CbGbCtD
Montelukast—CYP3A4—Ergocalciferol—osteoporosis	0.0232	0.0328	CbGbCtD
Montelukast—CYP2C9—Estradiol—osteoporosis	0.0207	0.0293	CbGbCtD
Montelukast—CYP3A4—Raloxifene—osteoporosis	0.0194	0.0274	CbGbCtD
Montelukast—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0187	0.0265	CbGbCtD
Montelukast—CYP3A4—Cholecalciferol—osteoporosis	0.015	0.0211	CbGbCtD
Montelukast—CYP3A4—Conjugated Estrogens—osteoporosis	0.0137	0.0194	CbGbCtD
Montelukast—CYP3A4—Estradiol—osteoporosis	0.0121	0.017	CbGbCtD
Montelukast—Body temperature increased—Alendronate—osteoporosis	0.000315	0.00126	CcSEcCtD
Montelukast—Abdominal pain—Alendronate—osteoporosis	0.000315	0.00126	CcSEcCtD
Montelukast—Muscle spasms—Conjugated Estrogens—osteoporosis	0.000314	0.00126	CcSEcCtD
Montelukast—Sinusitis—Estradiol—osteoporosis	0.000314	0.00126	CcSEcCtD
Montelukast—Nervous system disorder—Risedronate—osteoporosis	0.000313	0.00125	CcSEcCtD
Montelukast—Agitation—Zoledronate—osteoporosis	0.000312	0.00125	CcSEcCtD
Montelukast—Angioedema—Zoledronate—osteoporosis	0.00031	0.00124	CcSEcCtD
Montelukast—Skin disorder—Risedronate—osteoporosis	0.00031	0.00124	CcSEcCtD
Montelukast—Gastrointestinal pain—Calcitriol—osteoporosis	0.00031	0.00124	CcSEcCtD
Montelukast—Abdominal pain—Raloxifene—osteoporosis	0.000309	0.00124	CcSEcCtD
Montelukast—Body temperature increased—Raloxifene—osteoporosis	0.000309	0.00124	CcSEcCtD
Montelukast—Urticaria—Ibandronate—osteoporosis	0.000308	0.00123	CcSEcCtD
Montelukast—Abdominal pain—Ibandronate—osteoporosis	0.000306	0.00122	CcSEcCtD
Montelukast—Body temperature increased—Ibandronate—osteoporosis	0.000306	0.00122	CcSEcCtD
Montelukast—Oedema—Pamidronate—osteoporosis	0.000304	0.00121	CcSEcCtD
Montelukast—Anaphylactic shock—Pamidronate—osteoporosis	0.000304	0.00121	CcSEcCtD
Montelukast—Infection—Pamidronate—osteoporosis	0.000302	0.0012	CcSEcCtD
Montelukast—Rhinitis—Estradiol—osteoporosis	0.000301	0.0012	CcSEcCtD
Montelukast—Urticaria—Calcitriol—osteoporosis	0.000301	0.0012	CcSEcCtD
Montelukast—Hepatitis—Estradiol—osteoporosis	0.000301	0.0012	CcSEcCtD
Montelukast—Palpitations—Zoledronate—osteoporosis	0.0003	0.0012	CcSEcCtD
Montelukast—Abdominal pain—Calcitriol—osteoporosis	0.0003	0.0012	CcSEcCtD
Montelukast—Body temperature increased—Calcitriol—osteoporosis	0.0003	0.0012	CcSEcCtD
Montelukast—Hypoaesthesia—Estradiol—osteoporosis	0.000299	0.0012	CcSEcCtD
Montelukast—Angioedema—Conjugated Estrogens—osteoporosis	0.000299	0.00119	CcSEcCtD
Montelukast—Pharyngitis—Estradiol—osteoporosis	0.000298	0.00119	CcSEcCtD
Montelukast—Hypersensitivity—Estropipate—osteoporosis	0.000298	0.00119	CcSEcCtD
Montelukast—Nervous system disorder—Pamidronate—osteoporosis	0.000298	0.00119	CcSEcCtD
Montelukast—Thrombocytopenia—Pamidronate—osteoporosis	0.000297	0.00119	CcSEcCtD
Montelukast—Urinary tract disorder—Estradiol—osteoporosis	0.000297	0.00119	CcSEcCtD
Montelukast—Vomiting—Etidronic acid—osteoporosis	0.000297	0.00119	CcSEcCtD
Montelukast—Cough—Zoledronate—osteoporosis	0.000296	0.00118	CcSEcCtD
Montelukast—Connective tissue disorder—Estradiol—osteoporosis	0.000296	0.00118	CcSEcCtD
Montelukast—Urethral disorder—Estradiol—osteoporosis	0.000295	0.00118	CcSEcCtD
Montelukast—Rash—Etidronic acid—osteoporosis	0.000294	0.00118	CcSEcCtD
Montelukast—Convulsion—Zoledronate—osteoporosis	0.000294	0.00118	CcSEcCtD
Montelukast—Dermatitis—Etidronic acid—osteoporosis	0.000294	0.00118	CcSEcCtD
Montelukast—Hypersensitivity—Alendronate—osteoporosis	0.000293	0.00117	CcSEcCtD
Montelukast—Headache—Etidronic acid—osteoporosis	0.000293	0.00117	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000291	0.00116	CcSEcCtD
Montelukast—Asthenia—Estropipate—osteoporosis	0.00029	0.00116	CcSEcCtD
Montelukast—Arthralgia—Zoledronate—osteoporosis	0.000289	0.00116	CcSEcCtD
Montelukast—Myalgia—Zoledronate—osteoporosis	0.000289	0.00116	CcSEcCtD
Montelukast—Palpitations—Conjugated Estrogens—osteoporosis	0.000289	0.00115	CcSEcCtD
Montelukast—Insomnia—Risedronate—osteoporosis	0.000289	0.00115	CcSEcCtD
Montelukast—Anxiety—Zoledronate—osteoporosis	0.000288	0.00115	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000287	0.00115	CcSEcCtD
Montelukast—Paraesthesia—Risedronate—osteoporosis	0.000287	0.00115	CcSEcCtD
Montelukast—Pruritus—Estropipate—osteoporosis	0.000286	0.00114	CcSEcCtD
Montelukast—Asthenia—Alendronate—osteoporosis	0.000286	0.00114	CcSEcCtD
Montelukast—Hypersensitivity—Ibandronate—osteoporosis	0.000285	0.00114	CcSEcCtD
Montelukast—Cough—Conjugated Estrogens—osteoporosis	0.000285	0.00114	CcSEcCtD
Montelukast—Erythema multiforme—Estradiol—osteoporosis	0.000284	0.00114	CcSEcCtD
Montelukast—Convulsion—Conjugated Estrogens—osteoporosis	0.000283	0.00113	CcSEcCtD
Montelukast—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000283	0.00113	CcSEcCtD
Montelukast—Fatigue—Ethinyl Estradiol—osteoporosis	0.000282	0.00113	CcSEcCtD
Montelukast—Pruritus—Alendronate—osteoporosis	0.000282	0.00112	CcSEcCtD
Montelukast—Dyspepsia—Risedronate—osteoporosis	0.000281	0.00112	CcSEcCtD
Montelukast—Hypersensitivity—Calcitriol—osteoporosis	0.000279	0.00112	CcSEcCtD
Montelukast—Cardiac disorder—Estradiol—osteoporosis	0.000279	0.00111	CcSEcCtD
Montelukast—Myalgia—Conjugated Estrogens—osteoporosis	0.000278	0.00111	CcSEcCtD
Montelukast—Arthralgia—Conjugated Estrogens—osteoporosis	0.000278	0.00111	CcSEcCtD
Montelukast—Asthenia—Ibandronate—osteoporosis	0.000278	0.00111	CcSEcCtD
Montelukast—Anxiety—Conjugated Estrogens—osteoporosis	0.000278	0.00111	CcSEcCtD
Montelukast—Nausea—Etidronic acid—osteoporosis	0.000277	0.00111	CcSEcCtD
Montelukast—Oedema—Zoledronate—osteoporosis	0.000277	0.00111	CcSEcCtD
Montelukast—Anaphylactic shock—Zoledronate—osteoporosis	0.000277	0.00111	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000277	0.0011	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000277	0.0011	CcSEcCtD
Montelukast—Diarrhoea—Estropipate—osteoporosis	0.000276	0.0011	CcSEcCtD
Montelukast—Gastrointestinal disorder—Risedronate—osteoporosis	0.000276	0.0011	CcSEcCtD
Montelukast—Infection—Zoledronate—osteoporosis	0.000275	0.0011	CcSEcCtD
Montelukast—Fatigue—Risedronate—osteoporosis	0.000275	0.0011	CcSEcCtD
Montelukast—Insomnia—Pamidronate—osteoporosis	0.000275	0.0011	CcSEcCtD
Montelukast—Pruritus—Ibandronate—osteoporosis	0.000274	0.00109	CcSEcCtD
Montelukast—Pain—Risedronate—osteoporosis	0.000273	0.00109	CcSEcCtD
Montelukast—Paraesthesia—Pamidronate—osteoporosis	0.000273	0.00109	CcSEcCtD
Montelukast—Diarrhoea—Alendronate—osteoporosis	0.000272	0.00109	CcSEcCtD
Montelukast—Asthenia—Calcitriol—osteoporosis	0.000272	0.00109	CcSEcCtD
Montelukast—Nervous system disorder—Zoledronate—osteoporosis	0.000272	0.00109	CcSEcCtD
Montelukast—Immune system disorder—Estradiol—osteoporosis	0.000272	0.00108	CcSEcCtD
Montelukast—Thrombocytopenia—Zoledronate—osteoporosis	0.000271	0.00108	CcSEcCtD
Montelukast—Mediastinal disorder—Estradiol—osteoporosis	0.000271	0.00108	CcSEcCtD
Montelukast—Somnolence—Pamidronate—osteoporosis	0.00027	0.00108	CcSEcCtD
Montelukast—Skin disorder—Zoledronate—osteoporosis	0.000269	0.00108	CcSEcCtD
Montelukast—Pruritus—Calcitriol—osteoporosis	0.000268	0.00107	CcSEcCtD
Montelukast—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000268	0.00107	CcSEcCtD
Montelukast—Diarrhoea—Raloxifene—osteoporosis	0.000268	0.00107	CcSEcCtD
Montelukast—Dyspepsia—Pamidronate—osteoporosis	0.000267	0.00107	CcSEcCtD
Montelukast—Dizziness—Estropipate—osteoporosis	0.000267	0.00107	CcSEcCtD
Montelukast—Oedema—Conjugated Estrogens—osteoporosis	0.000267	0.00107	CcSEcCtD
Montelukast—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000267	0.00107	CcSEcCtD
Montelukast—Infection—Conjugated Estrogens—osteoporosis	0.000265	0.00106	CcSEcCtD
Montelukast—Diarrhoea—Ibandronate—osteoporosis	0.000265	0.00106	CcSEcCtD
Montelukast—Mental disorder—Estradiol—osteoporosis	0.000263	0.00105	CcSEcCtD
Montelukast—Dizziness—Alendronate—osteoporosis	0.000263	0.00105	CcSEcCtD
Montelukast—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000262	0.00105	CcSEcCtD
Montelukast—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000262	0.00105	CcSEcCtD
Montelukast—Fatigue—Pamidronate—osteoporosis	0.000262	0.00105	CcSEcCtD
Montelukast—Gastrointestinal pain—Risedronate—osteoporosis	0.000261	0.00104	CcSEcCtD
Montelukast—Urticaria—Ethinyl Estradiol—osteoporosis	0.00026	0.00104	CcSEcCtD
Montelukast—Pain—Pamidronate—osteoporosis	0.00026	0.00104	CcSEcCtD
Montelukast—Diarrhoea—Calcitriol—osteoporosis	0.000259	0.00104	CcSEcCtD
Montelukast—Skin disorder—Conjugated Estrogens—osteoporosis	0.000259	0.00104	CcSEcCtD
Montelukast—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000259	0.00103	CcSEcCtD
Montelukast—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000259	0.00103	CcSEcCtD
Montelukast—Dizziness—Raloxifene—osteoporosis	0.000259	0.00103	CcSEcCtD
Montelukast—Vomiting—Estropipate—osteoporosis	0.000257	0.00103	CcSEcCtD
Montelukast—Dizziness—Ibandronate—osteoporosis	0.000256	0.00102	CcSEcCtD
Montelukast—Rash—Estropipate—osteoporosis	0.000255	0.00102	CcSEcCtD
Montelukast—Dermatitis—Estropipate—osteoporosis	0.000255	0.00102	CcSEcCtD
Montelukast—Urticaria—Risedronate—osteoporosis	0.000254	0.00101	CcSEcCtD
Montelukast—Headache—Estropipate—osteoporosis	0.000253	0.00101	CcSEcCtD
Montelukast—Vomiting—Alendronate—osteoporosis	0.000253	0.00101	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000253	0.00101	CcSEcCtD
Montelukast—Abdominal pain—Risedronate—osteoporosis	0.000252	0.00101	CcSEcCtD
Montelukast—Body temperature increased—Risedronate—osteoporosis	0.000252	0.00101	CcSEcCtD
Montelukast—Muscle spasms—Estradiol—osteoporosis	0.000252	0.00101	CcSEcCtD
Montelukast—Rash—Alendronate—osteoporosis	0.000251	0.001	CcSEcCtD
Montelukast—Insomnia—Zoledronate—osteoporosis	0.000251	0.001	CcSEcCtD
Montelukast—Dermatitis—Alendronate—osteoporosis	0.000251	0.001	CcSEcCtD
Montelukast—Headache—Alendronate—osteoporosis	0.000249	0.000996	CcSEcCtD
Montelukast—Paraesthesia—Zoledronate—osteoporosis	0.000249	0.000994	CcSEcCtD
Montelukast—Vomiting—Raloxifene—osteoporosis	0.000249	0.000994	CcSEcCtD
Montelukast—Gastrointestinal pain—Pamidronate—osteoporosis	0.000248	0.000991	CcSEcCtD
Montelukast—Rash—Raloxifene—osteoporosis	0.000247	0.000986	CcSEcCtD
Montelukast—Dermatitis—Raloxifene—osteoporosis	0.000247	0.000985	CcSEcCtD
Montelukast—Somnolence—Zoledronate—osteoporosis	0.000246	0.000984	CcSEcCtD
Montelukast—Vomiting—Ibandronate—osteoporosis	0.000246	0.000984	CcSEcCtD
Montelukast—Tremor—Estradiol—osteoporosis	0.000245	0.00098	CcSEcCtD
Montelukast—Headache—Raloxifene—osteoporosis	0.000245	0.000979	CcSEcCtD
Montelukast—Rash—Ibandronate—osteoporosis	0.000244	0.000976	CcSEcCtD
Montelukast—Dermatitis—Ibandronate—osteoporosis	0.000244	0.000975	CcSEcCtD
Montelukast—Dyspepsia—Zoledronate—osteoporosis	0.000244	0.000975	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000243	0.000971	CcSEcCtD
Montelukast—Headache—Ibandronate—osteoporosis	0.000243	0.000969	CcSEcCtD
Montelukast—Insomnia—Conjugated Estrogens—osteoporosis	0.000241	0.000964	CcSEcCtD
Montelukast—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000241	0.000964	CcSEcCtD
Montelukast—Vomiting—Calcitriol—osteoporosis	0.000241	0.000963	CcSEcCtD
Montelukast—Agitation—Estradiol—osteoporosis	0.000241	0.000961	CcSEcCtD
Montelukast—Nausea—Estropipate—osteoporosis	0.00024	0.000959	CcSEcCtD
Montelukast—Body temperature increased—Pamidronate—osteoporosis	0.00024	0.000958	CcSEcCtD
Montelukast—Abdominal pain—Pamidronate—osteoporosis	0.00024	0.000958	CcSEcCtD
Montelukast—Paraesthesia—Conjugated Estrogens—osteoporosis	0.00024	0.000957	CcSEcCtD
Montelukast—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000239	0.000956	CcSEcCtD
Montelukast—Angioedema—Estradiol—osteoporosis	0.000239	0.000955	CcSEcCtD
Montelukast—Rash—Calcitriol—osteoporosis	0.000239	0.000955	CcSEcCtD
Montelukast—Fatigue—Zoledronate—osteoporosis	0.000239	0.000955	CcSEcCtD
Montelukast—Dermatitis—Calcitriol—osteoporosis	0.000239	0.000954	CcSEcCtD
Montelukast—Headache—Calcitriol—osteoporosis	0.000238	0.000949	CcSEcCtD
Montelukast—Somnolence—Conjugated Estrogens—osteoporosis	0.000237	0.000948	CcSEcCtD
Montelukast—Pain—Zoledronate—osteoporosis	0.000237	0.000947	CcSEcCtD
Montelukast—Nausea—Alendronate—osteoporosis	0.000236	0.000944	CcSEcCtD
Montelukast—Hypersensitivity—Risedronate—osteoporosis	0.000235	0.00094	CcSEcCtD
Montelukast—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000235	0.000939	CcSEcCtD
Montelukast—Asthenia—Ethinyl Estradiol—osteoporosis	0.000235	0.000938	CcSEcCtD
Montelukast—Nausea—Raloxifene—osteoporosis	0.000232	0.000929	CcSEcCtD
Montelukast—Pruritus—Ethinyl Estradiol—osteoporosis	0.000232	0.000925	CcSEcCtD
Montelukast—Palpitations—Estradiol—osteoporosis	0.000231	0.000924	CcSEcCtD
Montelukast—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.00023	0.000921	CcSEcCtD
Montelukast—Fatigue—Conjugated Estrogens—osteoporosis	0.00023	0.000919	CcSEcCtD
Montelukast—Nausea—Ibandronate—osteoporosis	0.00023	0.000919	CcSEcCtD
Montelukast—Asthenia—Risedronate—osteoporosis	0.000229	0.000915	CcSEcCtD
Montelukast—Cough—Estradiol—osteoporosis	0.000228	0.000912	CcSEcCtD
Montelukast—Pain—Conjugated Estrogens—osteoporosis	0.000228	0.000912	CcSEcCtD
Montelukast—Gastrointestinal pain—Zoledronate—osteoporosis	0.000227	0.000906	CcSEcCtD
Montelukast—Pruritus—Risedronate—osteoporosis	0.000226	0.000902	CcSEcCtD
Montelukast—Nausea—Calcitriol—osteoporosis	0.000225	0.0009	CcSEcCtD
Montelukast—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000224	0.000895	CcSEcCtD
Montelukast—Hypersensitivity—Pamidronate—osteoporosis	0.000224	0.000893	CcSEcCtD
Montelukast—Myalgia—Estradiol—osteoporosis	0.000223	0.00089	CcSEcCtD
Montelukast—Arthralgia—Estradiol—osteoporosis	0.000223	0.00089	CcSEcCtD
Montelukast—Anxiety—Estradiol—osteoporosis	0.000222	0.000887	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000221	0.000884	CcSEcCtD
Montelukast—Urticaria—Zoledronate—osteoporosis	0.00022	0.00088	CcSEcCtD
Montelukast—Body temperature increased—Zoledronate—osteoporosis	0.000219	0.000875	CcSEcCtD
Montelukast—Abdominal pain—Zoledronate—osteoporosis	0.000219	0.000875	CcSEcCtD
Montelukast—Diarrhoea—Risedronate—osteoporosis	0.000218	0.000873	CcSEcCtD
Montelukast—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000218	0.000872	CcSEcCtD
Montelukast—Asthenia—Pamidronate—osteoporosis	0.000218	0.00087	CcSEcCtD
Montelukast—Dizziness—Ethinyl Estradiol—osteoporosis	0.000217	0.000865	CcSEcCtD
Montelukast—Pruritus—Pamidronate—osteoporosis	0.000215	0.000858	CcSEcCtD
Montelukast—Anaphylactic shock—Estradiol—osteoporosis	0.000214	0.000853	CcSEcCtD
Montelukast—Oedema—Estradiol—osteoporosis	0.000214	0.000853	CcSEcCtD
Montelukast—Infection—Estradiol—osteoporosis	0.000212	0.000848	CcSEcCtD
Montelukast—Urticaria—Conjugated Estrogens—osteoporosis	0.000212	0.000847	CcSEcCtD
Montelukast—Dizziness—Risedronate—osteoporosis	0.000211	0.000843	CcSEcCtD
Montelukast—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000211	0.000843	CcSEcCtD
Montelukast—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000211	0.000843	CcSEcCtD
Montelukast—Nervous system disorder—Estradiol—osteoporosis	0.00021	0.000837	CcSEcCtD
Montelukast—Vomiting—Ethinyl Estradiol—osteoporosis	0.000208	0.000832	CcSEcCtD
Montelukast—Diarrhoea—Pamidronate—osteoporosis	0.000208	0.00083	CcSEcCtD
Montelukast—Skin disorder—Estradiol—osteoporosis	0.000208	0.000829	CcSEcCtD
Montelukast—Rash—Ethinyl Estradiol—osteoporosis	0.000206	0.000825	CcSEcCtD
Montelukast—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000206	0.000824	CcSEcCtD
Montelukast—Headache—Ethinyl Estradiol—osteoporosis	0.000205	0.000819	CcSEcCtD
Montelukast—Hypersensitivity—Zoledronate—osteoporosis	0.000204	0.000816	CcSEcCtD
Montelukast—Vomiting—Risedronate—osteoporosis	0.000203	0.000811	CcSEcCtD
Montelukast—Rash—Risedronate—osteoporosis	0.000201	0.000804	CcSEcCtD
Montelukast—Dermatitis—Risedronate—osteoporosis	0.000201	0.000803	CcSEcCtD
Montelukast—Dizziness—Pamidronate—osteoporosis	0.000201	0.000802	CcSEcCtD
Montelukast—Headache—Risedronate—osteoporosis	0.0002	0.000799	CcSEcCtD
Montelukast—Asthenia—Zoledronate—osteoporosis	0.000199	0.000795	CcSEcCtD
Montelukast—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000197	0.000786	CcSEcCtD
Montelukast—Pruritus—Zoledronate—osteoporosis	0.000196	0.000783	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000195	0.000778	CcSEcCtD
Montelukast—Nausea—Ethinyl Estradiol—osteoporosis	0.000195	0.000777	CcSEcCtD
Montelukast—Insomnia—Estradiol—osteoporosis	0.000193	0.000772	CcSEcCtD
Montelukast—Vomiting—Pamidronate—osteoporosis	0.000193	0.000771	CcSEcCtD
Montelukast—Paraesthesia—Estradiol—osteoporosis	0.000192	0.000766	CcSEcCtD
Montelukast—Asthenia—Conjugated Estrogens—osteoporosis	0.000192	0.000765	CcSEcCtD
Montelukast—Rash—Pamidronate—osteoporosis	0.000191	0.000764	CcSEcCtD
Montelukast—Dermatitis—Pamidronate—osteoporosis	0.000191	0.000764	CcSEcCtD
Montelukast—Headache—Pamidronate—osteoporosis	0.00019	0.00076	CcSEcCtD
Montelukast—Somnolence—Estradiol—osteoporosis	0.00019	0.000759	CcSEcCtD
Montelukast—Diarrhoea—Zoledronate—osteoporosis	0.00019	0.000758	CcSEcCtD
Montelukast—Nausea—Risedronate—osteoporosis	0.00019	0.000758	CcSEcCtD
Montelukast—Pruritus—Conjugated Estrogens—osteoporosis	0.000189	0.000754	CcSEcCtD
Montelukast—Dyspepsia—Estradiol—osteoporosis	0.000188	0.000751	CcSEcCtD
Montelukast—Gastrointestinal disorder—Estradiol—osteoporosis	0.000184	0.000737	CcSEcCtD
Montelukast—Fatigue—Estradiol—osteoporosis	0.000184	0.000736	CcSEcCtD
Montelukast—Dizziness—Zoledronate—osteoporosis	0.000183	0.000732	CcSEcCtD
Montelukast—Pain—Estradiol—osteoporosis	0.000183	0.00073	CcSEcCtD
Montelukast—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000183	0.00073	CcSEcCtD
Montelukast—Nausea—Pamidronate—osteoporosis	0.00018	0.00072	CcSEcCtD
Montelukast—Dizziness—Conjugated Estrogens—osteoporosis	0.000177	0.000705	CcSEcCtD
Montelukast—Vomiting—Zoledronate—osteoporosis	0.000176	0.000704	CcSEcCtD
Montelukast—Rash—Zoledronate—osteoporosis	0.000175	0.000698	CcSEcCtD
Montelukast—Gastrointestinal pain—Estradiol—osteoporosis	0.000175	0.000698	CcSEcCtD
Montelukast—Dermatitis—Zoledronate—osteoporosis	0.000175	0.000698	CcSEcCtD
Montelukast—Headache—Zoledronate—osteoporosis	0.000174	0.000694	CcSEcCtD
Montelukast—Vomiting—Conjugated Estrogens—osteoporosis	0.00017	0.000678	CcSEcCtD
Montelukast—Urticaria—Estradiol—osteoporosis	0.00017	0.000678	CcSEcCtD
Montelukast—Abdominal pain—Estradiol—osteoporosis	0.000169	0.000675	CcSEcCtD
Montelukast—Body temperature increased—Estradiol—osteoporosis	0.000169	0.000675	CcSEcCtD
Montelukast—Rash—Conjugated Estrogens—osteoporosis	0.000168	0.000672	CcSEcCtD
Montelukast—Dermatitis—Conjugated Estrogens—osteoporosis	0.000168	0.000672	CcSEcCtD
Montelukast—Headache—Conjugated Estrogens—osteoporosis	0.000167	0.000668	CcSEcCtD
Montelukast—Nausea—Zoledronate—osteoporosis	0.000165	0.000658	CcSEcCtD
Montelukast—Nausea—Conjugated Estrogens—osteoporosis	0.000159	0.000633	CcSEcCtD
Montelukast—Hypersensitivity—Estradiol—osteoporosis	0.000157	0.000629	CcSEcCtD
Montelukast—Asthenia—Estradiol—osteoporosis	0.000153	0.000612	CcSEcCtD
Montelukast—Pruritus—Estradiol—osteoporosis	0.000151	0.000604	CcSEcCtD
Montelukast—Diarrhoea—Estradiol—osteoporosis	0.000146	0.000584	CcSEcCtD
Montelukast—Dizziness—Estradiol—osteoporosis	0.000141	0.000564	CcSEcCtD
Montelukast—Vomiting—Estradiol—osteoporosis	0.000136	0.000543	CcSEcCtD
Montelukast—Rash—Estradiol—osteoporosis	0.000135	0.000538	CcSEcCtD
Montelukast—Dermatitis—Estradiol—osteoporosis	0.000135	0.000538	CcSEcCtD
Montelukast—Headache—Estradiol—osteoporosis	0.000134	0.000535	CcSEcCtD
Montelukast—PTGS1—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000128	0.00303	CbGpPWpGaD
Montelukast—Nausea—Estradiol—osteoporosis	0.000127	0.000507	CcSEcCtD
Montelukast—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000125	0.00297	CbGpPWpGaD
Montelukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	0.000125	0.00297	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—CNR2—osteoporosis	0.000125	0.00296	CbGpPWpGaD
Montelukast—CYP2A6—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000121	0.00287	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—WNT1—osteoporosis	0.000117	0.00278	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—PTHLH—osteoporosis	0.000117	0.00277	CbGpPWpGaD
Montelukast—ALOX5—Selenium Micronutrient Network—IL6—osteoporosis	0.000116	0.00276	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—MGLL—osteoporosis	0.000114	0.00271	CbGpPWpGaD
Montelukast—CYP2C9—Biological oxidations—CYP27A1—osteoporosis	0.000113	0.00268	CbGpPWpGaD
Montelukast—PTGS1—Biological oxidations—CYP19A1—osteoporosis	0.000113	0.00268	CbGpPWpGaD
Montelukast—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	0.000112	0.00267	CbGpPWpGaD
Montelukast—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000112	0.00265	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—LRP5—osteoporosis	0.000111	0.00265	CbGpPWpGaD
Montelukast—CYP2C9—Metapathway biotransformation—CYP27A1—osteoporosis	0.000111	0.00264	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—CA2—osteoporosis	0.000109	0.00258	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—OXCT1—osteoporosis	0.000109	0.00258	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—LRP6—osteoporosis	0.000107	0.00253	CbGpPWpGaD
Montelukast—CYP2A6—Biological oxidations—CYP19A1—osteoporosis	0.000107	0.00253	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—PTHLH—osteoporosis	0.000106	0.00252	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—MGLL—osteoporosis	0.000106	0.00252	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000106	0.00251	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000103	0.00245	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—CALCA—osteoporosis	0.000103	0.00244	CbGpPWpGaD
Montelukast—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000102	0.00242	CbGpPWpGaD
Montelukast—ALOX5—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	9.98e-05	0.00237	CbGpPWpGaD
Montelukast—CYP2A6—NRF2 pathway—AGER—osteoporosis	9.96e-05	0.00237	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR ligand binding—POMC—osteoporosis	9.51e-05	0.00226	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—CALCA—osteoporosis	9.33e-05	0.00222	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	9.27e-05	0.0022	CbGpPWpGaD
Montelukast—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	9.08e-05	0.00216	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—TLN1—osteoporosis	9e-05	0.00214	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—IDH2—osteoporosis	9e-05	0.00214	CbGpPWpGaD
Montelukast—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	8.96e-05	0.00213	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	8.79e-05	0.00209	CbGpPWpGaD
Montelukast—PTGS1—Selenium Micronutrient Network—IL1B—osteoporosis	8.59e-05	0.00204	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—CYP27A1—osteoporosis	8.46e-05	0.00201	CbGpPWpGaD
Montelukast—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	8.27e-05	0.00197	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	8.24e-05	0.00196	CbGpPWpGaD
Montelukast—CYP2C8—Phase 1 - Functionalization of compounds—POMC—osteoporosis	8.24e-05	0.00196	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—ACP5—osteoporosis	8.23e-05	0.00196	CbGpPWpGaD
Montelukast—ALOX5—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	8.13e-05	0.00193	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—P4HB—osteoporosis	7.76e-05	0.00185	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—TPI1—osteoporosis	7.65e-05	0.00182	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PTH—osteoporosis	7.55e-05	0.00179	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	7.54e-05	0.00179	CbGpPWpGaD
Montelukast—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	7.44e-05	0.00177	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—RAP1A—osteoporosis	7.42e-05	0.00176	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CNR2—osteoporosis	7.36e-05	0.00175	CbGpPWpGaD
Montelukast—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	7.36e-05	0.00175	CbGpPWpGaD
Montelukast—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	7.34e-05	0.00174	CbGpPWpGaD
Montelukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	7.33e-05	0.00174	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—ADCY5—osteoporosis	7.31e-05	0.00174	CbGpPWpGaD
Montelukast—CYP2C8—Biological oxidations—CYP19A1—osteoporosis	7.28e-05	0.00173	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—NFATC1—osteoporosis	7.24e-05	0.00172	CbGpPWpGaD
Montelukast—SLCO2B1—Transmembrane transport of small molecules—ADCY5—osteoporosis	7.21e-05	0.00171	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—P4HB—osteoporosis	7.2e-05	0.00171	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—DKK1—osteoporosis	7.18e-05	0.00171	CbGpPWpGaD
Montelukast—CYP2C8—Metapathway biotransformation—CYP19A1—osteoporosis	7.18e-05	0.00171	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	7.15e-05	0.0017	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—GAPDH—osteoporosis	7.06e-05	0.00168	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	7.01e-05	0.00167	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—WNT1—osteoporosis	6.92e-05	0.00164	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—RAP1A—osteoporosis	6.88e-05	0.00164	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	6.83e-05	0.00162	CbGpPWpGaD
Montelukast—PTGS1—Biological oxidations—POMC—osteoporosis	6.77e-05	0.00161	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—FGA—osteoporosis	6.73e-05	0.0016	CbGpPWpGaD
Montelukast—CYP2C9—Phase 1 - Functionalization of compounds—POMC—osteoporosis	6.7e-05	0.00159	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	6.66e-05	0.00158	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—ADCY5—osteoporosis	6.63e-05	0.00158	CbGpPWpGaD
Montelukast—CYP2A6—Biological oxidations—POMC—osteoporosis	6.41e-05	0.00152	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PKM—osteoporosis	6.39e-05	0.00152	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—FDPS—osteoporosis	6.39e-05	0.00152	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PTHLH—osteoporosis	6.26e-05	0.00149	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—BMP2—osteoporosis	6.26e-05	0.00149	CbGpPWpGaD
Montelukast—PTGS1—Selenium Micronutrient Network—TNF—osteoporosis	6.24e-05	0.00148	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—FGB—osteoporosis	6.12e-05	0.00146	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PGLS—osteoporosis	6.06e-05	0.00144	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—GPD2—osteoporosis	6.06e-05	0.00144	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PKM—osteoporosis	6.04e-05	0.00144	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—FDPS—osteoporosis	6.04e-05	0.00144	CbGpPWpGaD
Montelukast—ALOX5—Metabolism of lipids and lipoproteins—POMC—osteoporosis	6e-05	0.00143	CbGpPWpGaD
Montelukast—CYP2C9—Biological oxidations—CYP19A1—osteoporosis	5.93e-05	0.00141	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PSMA5—osteoporosis	5.91e-05	0.00141	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PSMA2—osteoporosis	5.91e-05	0.00141	CbGpPWpGaD
Montelukast—CYP2C9—Metapathway biotransformation—CYP19A1—osteoporosis	5.84e-05	0.00139	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GPD2—osteoporosis	5.73e-05	0.00136	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PGLS—osteoporosis	5.73e-05	0.00136	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—ENO1—osteoporosis	5.56e-05	0.00132	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	5.56e-05	0.00132	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PNP—osteoporosis	5.54e-05	0.00132	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—ATIC—osteoporosis	5.54e-05	0.00132	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CALCA—osteoporosis	5.51e-05	0.00131	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PSMA2—osteoporosis	5.48e-05	0.0013	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PSMA5—osteoporosis	5.48e-05	0.0013	CbGpPWpGaD
Montelukast—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	5.45e-05	0.0013	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	5.42e-05	0.00129	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—POMC—osteoporosis	5.37e-05	0.00128	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	5.32e-05	0.00127	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PNP—osteoporosis	5.24e-05	0.00125	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—ATIC—osteoporosis	5.24e-05	0.00125	CbGpPWpGaD
Montelukast—PTGS1—Selenium Micronutrient Network—IL6—osteoporosis	5.03e-05	0.0012	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—KL—osteoporosis	5e-05	0.00119	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—POMC—osteoporosis	4.88e-05	0.00116	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—IL6R—osteoporosis	4.76e-05	0.00113	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CA2—osteoporosis	4.71e-05	0.00112	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—OXCT1—osteoporosis	4.71e-05	0.00112	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—MGLL—osteoporosis	4.59e-05	0.00109	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	4.53e-05	0.00108	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—OXCT1—osteoporosis	4.45e-05	0.00106	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CA2—osteoporosis	4.45e-05	0.00106	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—CYP19A1—osteoporosis	4.45e-05	0.00106	CbGpPWpGaD
Montelukast—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	4.42e-05	0.00105	CbGpPWpGaD
Montelukast—CYP2C8—Biological oxidations—POMC—osteoporosis	4.38e-05	0.00104	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—MGLL—osteoporosis	4.34e-05	0.00103	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	4.33e-05	0.00103	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	4.33e-05	0.00103	CbGpPWpGaD
Montelukast—CYP2A6—NRF2 pathway—TGFB1—osteoporosis	4.21e-05	0.001	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PKM—osteoporosis	4.13e-05	0.000981	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—FDPS—osteoporosis	4.13e-05	0.000981	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—ADCY5—osteoporosis	3.92e-05	0.000931	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PGLS—osteoporosis	3.91e-05	0.00093	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GPD2—osteoporosis	3.91e-05	0.00093	CbGpPWpGaD
Montelukast—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	3.91e-05	0.000929	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—IDH2—osteoporosis	3.9e-05	0.000928	CbGpPWpGaD
Montelukast—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	3.85e-05	0.000916	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—SPP1—osteoporosis	3.79e-05	0.000901	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—IDH2—osteoporosis	3.69e-05	0.000877	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	3.68e-05	0.000875	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CYP27A1—osteoporosis	3.67e-05	0.000872	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—ADCY5—osteoporosis	3.63e-05	0.000863	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—GPX1—osteoporosis	3.62e-05	0.00086	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ATIC—osteoporosis	3.58e-05	0.00085	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PNP—osteoporosis	3.58e-05	0.00085	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—ACP5—osteoporosis	3.57e-05	0.000848	CbGpPWpGaD
Montelukast—CYP2C9—Biological oxidations—POMC—osteoporosis	3.56e-05	0.000846	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.52e-05	0.000838	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CYP27A1—osteoporosis	3.47e-05	0.000825	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—IRS2—osteoporosis	3.43e-05	0.000815	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—ACP5—osteoporosis	3.38e-05	0.000802	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PKM—osteoporosis	3.36e-05	0.000798	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—FDPS—osteoporosis	3.36e-05	0.000798	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—LEP—osteoporosis	3.36e-05	0.000797	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—MTHFR—osteoporosis	3.34e-05	0.000794	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—TPI1—osteoporosis	3.32e-05	0.000789	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—ESR1—osteoporosis	3.2e-05	0.000761	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PGLS—osteoporosis	3.18e-05	0.000757	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GPD2—osteoporosis	3.18e-05	0.000757	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—TPI1—osteoporosis	3.14e-05	0.000746	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—P4HB—osteoporosis	3.12e-05	0.000742	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—GAPDH—osteoporosis	3.06e-05	0.000728	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CA2—osteoporosis	3.04e-05	0.000723	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—OXCT1—osteoporosis	3.04e-05	0.000723	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—IRS1—osteoporosis	2.99e-05	0.000711	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—RAP1A—osteoporosis	2.98e-05	0.000709	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—MGLL—osteoporosis	2.97e-05	0.000705	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—P4HB—osteoporosis	2.95e-05	0.000701	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PNP—osteoporosis	2.91e-05	0.000692	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ATIC—osteoporosis	2.91e-05	0.000692	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GAPDH—osteoporosis	2.9e-05	0.000688	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—POMC—osteoporosis	2.88e-05	0.000685	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—RAP1A—osteoporosis	2.82e-05	0.00067	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—IL6R—osteoporosis	2.81e-05	0.000668	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.8e-05	0.000665	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—IGF1—osteoporosis	2.77e-05	0.000659	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—POMC—osteoporosis	2.67e-05	0.000635	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.6e-05	0.000618	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—IDH2—osteoporosis	2.52e-05	0.000599	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CA2—osteoporosis	2.48e-05	0.000589	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—OXCT1—osteoporosis	2.48e-05	0.000589	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—MGLL—osteoporosis	2.41e-05	0.000574	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—ENO1—osteoporosis	2.41e-05	0.000573	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PSMA2—osteoporosis	2.38e-05	0.000565	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PSMA5—osteoporosis	2.38e-05	0.000565	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CYP27A1—osteoporosis	2.37e-05	0.000563	CbGpPWpGaD
Montelukast—CYP3A4—Biological oxidations—POMC—osteoporosis	2.35e-05	0.000558	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ACP5—osteoporosis	2.31e-05	0.000548	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—ENO1—osteoporosis	2.28e-05	0.000542	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.28e-05	0.000541	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.28e-05	0.000541	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PSMA2—osteoporosis	2.25e-05	0.000534	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PSMA5—osteoporosis	2.25e-05	0.000534	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—FDPS—osteoporosis	2.22e-05	0.000527	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PKM—osteoporosis	2.22e-05	0.000527	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—TPI1—osteoporosis	2.14e-05	0.00051	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—IL6—osteoporosis	2.12e-05	0.000504	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PGLS—osteoporosis	2.1e-05	0.000499	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GPD2—osteoporosis	2.1e-05	0.000499	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—IDH2—osteoporosis	2.05e-05	0.000488	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—P4HB—osteoporosis	2.02e-05	0.000479	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GAPDH—osteoporosis	1.98e-05	0.00047	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CYP27A1—osteoporosis	1.93e-05	0.000459	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CYP19A1—osteoporosis	1.93e-05	0.000458	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—RAP1A—osteoporosis	1.93e-05	0.000458	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ATIC—osteoporosis	1.92e-05	0.000456	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PNP—osteoporosis	1.92e-05	0.000456	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ACP5—osteoporosis	1.88e-05	0.000446	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.85e-05	0.00044	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CYP19A1—osteoporosis	1.82e-05	0.000433	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—TPI1—osteoporosis	1.74e-05	0.000415	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.68e-05	0.000399	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—MYC—osteoporosis	1.67e-05	0.000396	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—TGFB1—osteoporosis	1.66e-05	0.000395	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—P4HB—osteoporosis	1.64e-05	0.00039	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CA2—osteoporosis	1.63e-05	0.000388	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—OXCT1—osteoporosis	1.63e-05	0.000388	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GAPDH—osteoporosis	1.61e-05	0.000383	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—MGLL—osteoporosis	1.59e-05	0.000378	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—ADCY5—osteoporosis	1.58e-05	0.000374	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—GPX1—osteoporosis	1.57e-05	0.000373	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—RAP1A—osteoporosis	1.57e-05	0.000373	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ENO1—osteoporosis	1.56e-05	0.00037	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PSMA5—osteoporosis	1.53e-05	0.000365	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PSMA2—osteoporosis	1.53e-05	0.000365	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—ADCY5—osteoporosis	1.49e-05	0.000354	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GPX1—osteoporosis	1.48e-05	0.000353	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—MTHFR—osteoporosis	1.45e-05	0.000344	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—MTHFR—osteoporosis	1.37e-05	0.000326	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.37e-05	0.000325	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—IDH2—osteoporosis	1.35e-05	0.000322	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.27e-05	0.000302	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ENO1—osteoporosis	1.27e-05	0.000301	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—IL6—osteoporosis	1.25e-05	0.000298	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PSMA2—osteoporosis	1.25e-05	0.000297	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PSMA5—osteoporosis	1.25e-05	0.000297	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CYP19A1—osteoporosis	1.25e-05	0.000296	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ACP5—osteoporosis	1.24e-05	0.000294	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—POMC—osteoporosis	1.16e-05	0.000275	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—TPI1—osteoporosis	1.15e-05	0.000273	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—POMC—osteoporosis	1.1e-05	0.00026	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—P4HB—osteoporosis	1.08e-05	0.000257	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GAPDH—osteoporosis	1.06e-05	0.000252	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—RAP1A—osteoporosis	1.03e-05	0.000246	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ADCY5—osteoporosis	1.02e-05	0.000242	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GPX1—osteoporosis	1.01e-05	0.000241	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CYP19A1—osteoporosis	1.01e-05	0.000241	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—MTHFR—osteoporosis	9.36e-06	0.000222	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ENO1—osteoporosis	8.36e-06	0.000199	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ADCY5—osteoporosis	8.28e-06	0.000197	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GPX1—osteoporosis	8.25e-06	0.000196	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PSMA5—osteoporosis	8.24e-06	0.000196	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PSMA2—osteoporosis	8.24e-06	0.000196	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—MTHFR—osteoporosis	7.62e-06	0.000181	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—POMC—osteoporosis	7.48e-06	0.000178	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CYP19A1—osteoporosis	6.68e-06	0.000159	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—POMC—osteoporosis	6.09e-06	0.000145	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ADCY5—osteoporosis	5.46e-06	0.00013	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GPX1—osteoporosis	5.44e-06	0.000129	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—MTHFR—osteoporosis	5.02e-06	0.000119	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—POMC—osteoporosis	4.02e-06	9.55e-05	CbGpPWpGaD
